Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 14, 2022 | Series B | ¥400M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Longqian Capital | — | Series B |